| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.636 | 0.009 | 0.636 | Nootropic | 0.539 0.015 DBMET03205 | ||
| 0.45 | 0.006 | 0.45 | Tyrosine-protein kinase receptor antagonist | 0.19 0.044 DBMET03205 | ||
| 0.459 | 0.015 | 0.459 | Anticonvulsant | 0.284 0.045 DBMET03205 | ||
| 0.405 | 0.011 | 0.405 | TRKC antagonist | 0.255 0.046 DBMET03205 | ||
| 0.456 | 0.063 | 0.456 | Analgesic | |||
| 0.375 | 0.005 | 0.375 | TRKB antagonist | 0.263 0.015 DBMET03205 | ||
| 0.251 | 0.019 | 0.251 | TRKA antagonist | 0.132 0.059 DBMET03205 | ||
| 0.379 | 0.152 | 0.382 | Antiinflammatory | 0.382 0.15 DBMET03205 | DBMET03205 | |
| 0.308 | 0.128 | 0.308 | MAP kinase kinase 6 inhibitor | 0.256 0.182 DBMET03205 | ||
| 0.205 | 0.038 | 0.205 | Protein kinase (CK1) inhibitor | 0.144 0.072 DBMET03205 | ||
| 0.186 | 0.03 | 0.382 | Glutamate receptor antagonist | 0.382 0.005 DBMET03205 | DBMET03205 | |
| 0.173 | 0.04 | 0.173 | Protein kinase (CK1) delta inhibitor | 0.123 0.071 DBMET03205 | ||
| 0.157 | 0.025 | 0.157 | Activin receptor-like kinase 4 inhibitor | 0.121 0.051 DBMET03205 | ||
| 0.199 | 0.069 | 0.199 | Tyrosine kinase inhibitor | |||
| 0.153 | 0.024 | 0.153 | Sphingosine 1-phosphate receptor 2 agonist | 0.132 0.04 DBMET03205 | ||
| 0.136 | 0.008 | 0.136 | Toll-Like receptor 7 antagonist | 0.101 0.02 DBMET03205 | ||
| 0.142 | 0.022 | 0.142 | Interleukin 2 antagonist | |||
| 0.126 | 0.008 | 0.126 | 5 Hydroxytryptamine 3A antagonist | 0.065 0.048 DBMET03205 | ||
| 0.161 | 0.051 | 0.209 | Phosphodiesterase inhibitor | 0.209 0.032 DBMET03205 | DBMET03205 | |
| 0.22 | 0.116 | 0.22 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.192 0.191 DBMET03205 | ||
| 0.106 | 0.005 | 0.106 | Bromodomain-containing protein 3 inhibitor | 0.098 0.005 DBMET03205 | ||
| 0.122 | 0.028 | 0.122 | Janus tyrosine kinase 2 inhibitor | |||
| 0.124 | 0.035 | 0.124 | Acetylcholine agonist | |||
| 0.111 | 0.029 | 0.115 | Glutamate (mGluR) antagonist | 0.115 0.028 DBMET03205 | DBMET03205 | |
| 0.099 | 0.027 | 0.099 | Cyclin-dependent kinase 4 inhibitor | |||
| 0.096 | 0.028 | 0.096 | Protein kinase B beta inhibitor | 0.082 0.04 DBMET03205 | ||
| 0.141 | 0.072 | 0.141 | Ribosomal protein S6 kinase inhibitor | |||
| 0.125 | 0.058 | 0.125 | Glycogen synthase kinase-3 beta inhibitor | |||
| 0.094 | 0.029 | 0.095 | Glutamate (mGluR group I) antagonist | 0.095 0.028 DBMET03205 | DBMET03205 | |
| 0.077 | 0.016 | 0.077 | Protein kinase C theta inhibitor | |||
| 0.093 | 0.033 | 0.093 | Transforming growth factor beta 3 antagonist | 0.081 0.06 DBMET03205 | ||
| 0.144 | 0.086 | 0.144 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.073 | 0.015 | 0.073 | Phosphodiesterase X inhibitor | 0.061 0.02 DBMET03205 | ||
| 0.073 | 0.015 | 0.073 | Phosphodiesterase 10A inhibitor | 0.061 0.02 DBMET03205 | ||
| 0.098 | 0.043 | 0.098 | Bromodomain-containing protein 2 inhibitor | |||
| 0.134 | 0.081 | 0.134 | Activin receptor-like kinase 2 inhibitor | |||
| 0.207 | 0.156 | 0.207 | Immunomodulator | |||
| 0.091 | 0.044 | 0.091 | Acetylcholine nicotinic agonist | |||
| 0.124 | 0.079 | 0.124 | Toll-Like receptor antagonist | |||
| 0.112 | 0.068 | 0.112 | Glycogen synthase kinase-3 inhibitor | 0.101 0.078 DBMET03205 | ||
| 0.079 | 0.036 | 0.079 | Transforming growth factor antagonist | |||
| 0.102 | 0.062 | 0.102 | Hedgehog signaling inhibitor | |||
| 0.093 | 0.054 | 0.093 | Pim-3 kinase inhibitor | |||
| 0.064 | 0.027 | 0.064 | Pim-2 kinase inhibitor | |||
| 0.059 | 0.023 | 0.059 | Glutamate (mGluR5) antagonist | 0.05 0.029 DBMET03205 | ||
| 0.09 | 0.057 | 0.09 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | |||
| 0.062 | 0.03 | 0.062 | GABA receptor antagonist | |||
| 0.077 | 0.047 | 0.077 | Janus tyrosine kinase 3 inhibitor | |||
| 0.084 | 0.056 | 0.084 | MAP-kinase-activated kinase inhibitor | |||
| 0.072 | 0.048 | 0.072 | Benzodiazepine agonist | |||
| 0.054 | 0.029 | 0.054 | Phosphatidylinositol 3-kinase beta inhibitor | |||
| 0.17 | 0.148 | 0.17 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.059 | 0.036 | 0.059 | Nicotinic neuronal receptor agonist | |||
| 0.07 | 0.048 | 0.07 | Protein kinase C beta inhibitor | |||
| 0.059 | 0.039 | 0.059 | Phosphatidylinositol 3-kinase delta inhibitor | |||
| 0.071 | 0.057 | 0.071 | MAP-kinase-activated kinase 2 inhibitor | |||
| 0.065 | 0.052 | 0.065 | Protein kinase C alpha inhibitor | |||
| 0.039 | 0.027 | 0.039 | Cyclin D3 inhibitor | |||
| 0.034 | 0.024 | 0.034 | CDK6/cyclin D3 inhibitor | |||
| 0.082 | 0.073 | 0.082 | Protein kinase C delta inhibitor | |||
| 0.05 | 0.041 | 0.05 | Toll-Like receptor 8 antagonist | |||
| 0.027 | 0.02 | 0.027 | Glucosylceramidase stimulant | |||
| 0.037 | 0.031 | 0.037 | MAP3K5 inhibitor | |||
| 0.051 | 0.047 | 0.051 | Phosphodiesterase II inhibitor | |||
| 0.082 | 0.078 | 0.082 | Pim-1 kinase inhibitor | |||
| 0.076 | 0.073 | 0.076 | CDK/cyclin complex inhibitor | |||
| 0.05 | 0.048 | 0.05 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.141 | 0.14 | 0.141 | HERG channel blocker | |||
| 0.035 | 0.056 | 0.068 | AMPA receptor antagonist | 0.068 0.021 DBMET03205 | DBMET03205 | |
| 0.016 | 0.056 | 0.031 | Protocollagen prolyl hydroxylase inhibitor | 0.031 0.014 DBMET03205 | DBMET03205 | |
| 0.02 | 0.099 | 0.031 | DNA topoisomerase IV inhibitor | 0.031 0.018 DBMET03205 | DBMET03205 | |
| 0.04 | 0.165 | 0.129 | HIV-1 integrase inhibitor | 0.129 0.012 DBMET03205 | DBMET03205 | |
| 0.018 | 0.287 | 0.07 | DNA gyrase inhibitor | 0.07 0.036 DBMET03205 | DBMET03205 | |
| 0.008 | 0.394 | 0.258 | NMDA 2B receptor antagonist | 0.258 0.005 DBMET03205 | DBMET03205 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |